Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2000 Jan;59(1):39–43. doi: 10.1136/ard.59.1.39

Macrovascular disease and systemic sclerosis

M Ho 1, D Veale 1, C Eastmond 1, G Nuki 1, J Belch 1
PMCID: PMC1752979  PMID: 10627425

Abstract

OBJECTIVE—To determine if macrovascular disease is more prevalent in systemic sclerosis (SSc) compared with unaffected subjects.
METHODS—54 patients with SSc (both limited and diffuse disease) and 43 unaffected control subjects of similar age and sex were recruited. All subjects underwent a basic screen for conventional atherosclerotic disease risk factors. All had non-invasive vascular assessments—that is, carotid duplex scanning and measurement of ankle brachial blood pressure index—to identify the presence of asymptomatic peripheral vascular disease.
RESULTS—33 of 52 (64%) patients had carotid artery disease compared with only 15 of 42 (35%) controls (p=0.007). Eleven (21%) of these patients had moderate disease compared with only two (5%) controls (NS). Nine of 53 (17%) SSc patients had evidence of peripheral arterial disease compared with no controls. This result was also statistically significant (p=0.003). There were no significant differences in the basic risk factor profile, which included cigarette smoking, systolic and diastolic blood pressure, cholesterol, trigyceride and glucose concentrations.
CONCLUSION—Macrovascular disease is more common in SSc. Screening of these patients may allow identification of "at risk" patients at an early stage and allow the study of treatments to attenuate the high rate of cardiovascular mortality in these patients.



Full Text

The Full Text of this article is available as a PDF (115.1 KB).

Figure 1  .

Figure 1  

Open in a new tab

Prevalence of carotid and peripheral arterial disease in SSc patients compared with controls.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTONOVYCH T. T., STEINGASZNER L. C. Pathological changes in progressive systemic sclerosis. Georgetown Med Bull. 1962 Aug;16:27–39. [PubMed] [Google Scholar]
  2. Belch J. J., Zoma A. A., Richards I. M., McLaughlin K., Forbes C. D., Sturrock R. D. Vascular damage and factor-VIII-related antigen in the rheumatic diseases. Rheumatol Int. 1987;7(3):107–111. doi: 10.1007/BF00270462. [DOI] [PubMed] [Google Scholar]
  3. Bernstein E. F., Fronek A. Current status of noninvasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Am. 1982 Jun;62(3):473–487. doi: 10.1016/s0039-6109(16)42739-8. [DOI] [PubMed] [Google Scholar]
  4. Bruckdorfer K. R., Hillary J. B., Bunce T., Vancheeswaran R., Black C. M. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum. 1995 Aug;38(8):1060–1067. doi: 10.1002/art.1780380807. [DOI] [PubMed] [Google Scholar]
  5. Bryan C., Howard Y., Brennan P., Black C., Silman A. Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol. 1996 Nov;35(11):1122–1126. doi: 10.1093/rheumatology/35.11.1122. [DOI] [PubMed] [Google Scholar]
  6. D'Angelo W. A., Fries J. F., Masi A. T., Shulman L. E. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969 Mar;46(3):428–440. doi: 10.1016/0002-9343(69)90044-8. [DOI] [PubMed] [Google Scholar]
  7. Duprez D., Clement D. L. Medical treatment of peripheral vascular disease: good or bad? Eur Heart J. 1992 Feb;13(2):149–151. doi: 10.1093/oxfordjournals.eurheartj.a060138. [DOI] [PubMed] [Google Scholar]
  8. Fowkes F. G., Housley E., Cawood E. H., Macintyre C. C., Ruckley C. V., Prescott R. J. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991 Jun;20(2):384–392. doi: 10.1093/ije/20.2.384. [DOI] [PubMed] [Google Scholar]
  9. Galt S. W., McDaniel M. D., Ault K. A., Mitchell J., Cronenwett J. L. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease. J Vasc Surg. 1991 Dec;14(6):747–756. doi: 10.1067/mva.1991.33419. [DOI] [PubMed] [Google Scholar]
  10. Jacobsen S., Halberg P., Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma) Br J Rheumatol. 1998 Jul;37(7):750–755. doi: 10.1093/rheumatology/37.7.750. [DOI] [PubMed] [Google Scholar]
  11. Johnson B. F., Verlato F., Bergelin R. O., Primozich J. F., Strandness E., Jr Clinical outcome in patients with mild and moderate carotid artery stenosis. J Vasc Surg. 1995 Jan;21(1):120–126. doi: 10.1016/s0741-5214(95)70250-4. [DOI] [PubMed] [Google Scholar]
  12. LEINWAND I., DURYEE A. W., RICHTER M. N. Scleroderma; based on a study of over 150 cases. Ann Intern Med. 1954 Nov;41(5):1003–1041. doi: 10.7326/0003-4819-41-5-1003. [DOI] [PubMed] [Google Scholar]
  13. Laing S., Greenhalgh R. M. The detection and progression of asymptomatic peripheral arterial disease. Br J Surg. 1983 Oct;70(10):628–630. doi: 10.1002/bjs.1800701017. [DOI] [PubMed] [Google Scholar]
  14. Larkin J. G., Belch J. J., Flanigan P., Forbes C. D., Frier B. M. Microvascular disease and limited joint mobility in diabetes. A comparison of fibrinolysis and prostacyclin in diabetes and systemic sclerosis. Diabet Med. 1988 Jan;5(1):53–56. doi: 10.1111/j.1464-5491.1988.tb00941.x. [DOI] [PubMed] [Google Scholar]
  15. Lau C. S., McLaren M., Belch J. J. Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon. Br J Rheumatol. 1991 Dec;30(6):433–436. doi: 10.1093/rheumatology/30.6.433. [DOI] [PubMed] [Google Scholar]
  16. Lau C. S., McLaren M., Mackay I., Belch J. J. Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon. Ann Rheum Dis. 1993 Jun;52(6):443–448. doi: 10.1136/ard.52.6.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lau C. S., O'Dowd A., Belch J. J. White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome. Ann Rheum Dis. 1992 Feb;51(2):249–252. doi: 10.1136/ard.51.2.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Leng G. C., Fowkes F. G., Lee A. J., Dunbar J., Housley E., Ruckley C. V. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ. 1996 Dec 7;313(7070):1440–1444. doi: 10.1136/bmj.313.7070.1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Masuda J., Ross R. Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. Arteriosclerosis. 1990 Mar-Apr;10(2):164–177. doi: 10.1161/01.atv.10.2.164. [DOI] [PubMed] [Google Scholar]
  20. Masuda J., Ross R. Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis. 1990 Mar-Apr;10(2):178–187. doi: 10.1161/01.atv.10.2.178. [DOI] [PubMed] [Google Scholar]
  21. Roederer G. O., Langlois Y. E., Jager K. A., Primozich J. F., Beach K. W., Phillips D. J., Strandness D. E., Jr The natural history of carotid arterial disease in asymptomatic patients with cervical bruits. Stroke. 1984 Jul-Aug;15(4):605–613. doi: 10.1161/01.str.15.4.605. [DOI] [PubMed] [Google Scholar]
  22. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801–809. doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  23. Stafford L., Englert H., Gover J., Bertouch J. Distribution of macrovascular disease in scleroderma. Ann Rheum Dis. 1998 Aug;57(8):476–479. doi: 10.1136/ard.57.8.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Torres M. A., Furst D. E. Treatment of generalized systemic sclerosis. Rheum Dis Clin North Am. 1990 Feb;16(1):217–241. [PubMed] [Google Scholar]
  25. Veale D. J., Collidge T. A., Belch J. J. Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis. 1995 Oct;54(10):853–855. doi: 10.1136/ard.54.10.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Vogt M. T., Cauley J. A., Newman A. B., Kuller L. H., Hulley S. B. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA. 1993 Jul 28;270(4):465–469. [PubMed] [Google Scholar]
  27. Vogt M. T., McKenna M., Anderson S. J., Wolfson S. K., Kuller L. H. The relationship between ankle-arm index and mortality in older men and women. J Am Geriatr Soc. 1993 May;41(5):523–530. doi: 10.1111/j.1532-5415.1993.tb01889.x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES